Recombinant human erythropoietin in end-stage renal disease
Bihl, G.
South African Medical Journal 92(8): 565
2002
ISSN/ISBN: 0256-9574 PMID: 12244602 Document Number: 544034
Document emailed within 1 workday
Related Documents
Adamson, W.; Egrie, J.C.; Browne, J.K.; Downing, M.R.; Eschbach, W. 1988: The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report Behring Institute Mitteilungen 1988(83): 188-192Yamazaki, C.; Watanabe, Y.; Sakamoto, N. 1993: Pharmacokinetic study of recombinant human erythropoietin treatment in pre-dialysis end stage renal disease patients Nihon Jinzo Gakkai Shi 35(11): 1233-1242
Dimitrakov, D.; Kunchev, E. 1992: Application of recombinant human erythropoietin in patients with polycystic kidney disease and chronic renal failure Folia Medica 34(1): 41-44
Dyjas, R.; Wiecek, A.; Kokot, F. 1996: Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO Przeglad Lekarski 53(6): 486-490
Lim, V.S. 1990: Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency? Seminars in Nephrology 10(2 Suppl. 1): 26-27
Wauters, J.P. 1990: Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency Revue Medicale de la Suisse Romande 110(11): 951-954
Pietrzyk, J.A.; Dyras, P.; Smolnik, T.; Szymowska, M. 1992: Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure Przeglad Lekarski 49(1-2): 61-65
Hotta, T.; Ogawa, H.; Saito, A.; Ito, A. 1991: Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure International Journal of Hematology 54(3): 195-200
Boratyńska, M.; Szewczyk, Z.; Nowakowska, B.; Baldy-Chudzik, K.; Pytel, A. 1995: Effect of recombinant human erythropoietin on kinetics of alloantibodies in patients awaiting renal allograft Przeglad Lekarski 52(9): 424-427
Suzuki, H.; Murakami, M.; Ichihara, A.; Saruta, T. 1992: Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin Nihon Jinzo Gakkai Shi 34(1): 79-84
Ksiazek, A.; Baranowska-Daca, E. 1993: Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S550-S552
Urra, J.M.; de la Torre, M.; Alcazar, R.; Peces, R. 1997: Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance Clinical Chemistry 43(5): 848-849
Virón, B.éa.; Kolta, A.; Kiladjian, J.J.; Mignon, F.; Mayeux, P.; Casadevall, N. 2002: Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance Nephrologie 23(1): 19-22
Swanepoel, C.R.; Moosa, M.R.; Rowland, G.F.; Meyers, A.M.; Botha, B.P.; Smart, A.J.; Goodman, R.; Schall, R.; Keogh, H.J.; Merrifield, E.H. 1996: Clinical experience with Repotin, a locally produced recombinant human erythropoietin, in the treatment of anaemia of chronic renal failure in South Africa South African Medical Journal 86(10): 1266-1269
Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Dimitrakov, D.; Kumchev, E.; Tllkian, E. 1994: Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure Folia Medica 36(3): 31-36
Laupacis, A. 1991: A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group Transplantation Proceedings 23(2): 1825-1826
Rosenberg, M.E.; Howe, R.B.; Zanjani, E.D.; Hostetter, T.H. 1989: The response of erythropoietin to dietary protein in human renal disease Journal of Laboratory and Clinical Medicine 113(6): 735-742
Jeffrey, R.F.; Kendall, R.G.; Prabhu, P.; Norfolk, D.R.; Will, E.J.; Davison, A.M. 1995: Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation Clinical Nephrology 44(4): 241-247
Drüeke, T.; Zins, B.; Bererhi, L.; Casadevall, N.; Varet, B. 1989: Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency Presse Medicale 18(25): 1235-1237